Literature DB >> 11492968

Natural history and prognostic models in primary sclerosing cholangitis.

J A Talwalkar1, K D Lindor.   

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by inflammation and fibrosis of the intra- and extra-hepatic bile ducts. Despite the recognition of immunological and genetic alterations cited as factors in its pathogenesis, the exact cause for PSC remains unknown. Observational cohort studies, however, have demonstrated that PSC is a progressive disease culminating in liver failure or death. Natural history assessment in PSC, however, has been complicated by variable rates of disease progression and the impact of clinical symptoms upon initial presentation. The development of mathematical models by multivariable regression techniques (most notably Cox proportional hazards regression) has allowed for an improved description of overall survival on an individual basis among patients with PSC. Additionally, these models have also been employed for determining the optimal selection and timing for liver transplantation when advanced disease is imminent. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11492968     DOI: 10.1053/bega.2001.0205

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  9 in total

1.  Treatment of Biliary Problems in Inflammatory Bowel Disease.

Authors:  Christopher S Huang; David R Lichtenstein
Journal:  Curr Treat Options Gastroenterol       Date:  2005-04

2.  Perinatal events and the risk of developing primary sclerosing cholangitis.

Authors:  Annika Bergquist; Scott M Montgomery; Ulrika Lund; Anders Ekbom; Rolf Olsson; Stefan Lindgren; Hanne Prytz; Rolf Hultcrantz; Ulrika Broomé
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 3.  Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.

Authors:  Francesca Saffioti; Kurinchi Selvan Gurusamy; Neil Hawkins; Clare D Toon; Emmanuel Tsochatzis; Brian R Davidson; Douglas Thorburn
Journal:  Cochrane Database Syst Rev       Date:  2017-03-28

4.  Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Vivian S Gainer; Su-Chun Cheng; Tianxi Cai; Peter Szolovits; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  J Crohns Colitis       Date:  2014-02-19       Impact factor: 9.071

Review 5.  Primary sclerosing cholangitis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

6.  Alcohol consumption in patients with primary sclerosing cholangitis.

Authors:  Hannes Hagström; Per Stål; Knut Stokkeland; Annika Bergquist
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

Review 7.  Primary sclerosing cholangitis: diagnostic and management challenges.

Authors:  Sanjeev Sirpal; Natasha Chandok
Journal:  Clin Exp Gastroenterol       Date:  2017-11-06

8.  Imaging features of COVID-19-associated secondary sclerosing cholangitis on magnetic resonance cholangiopancreatography: a retrospective analysis.

Authors:  Soleen Ghafoor; Manon Germann; Christoph Jüngst; Beat Müllhaupt; Cäcilia S Reiner; Daniel Stocker
Journal:  Insights Imaging       Date:  2022-08-08

9.  Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases.

Authors:  Silke Leonhardt; Wilfried Veltzke-Schlieker; Andreas Adler; Eckart Schott; Dennis Eurich; Wladimir Faber; Peter Neuhaus; Daniel Seehofer
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.